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resuscitation before registering as general practitioners; hands-
on courses on mannequins done at frequent intervals are also 
recommended. The National Committee on Confidential Enquiries 
into Maternal Deaths is promoting essential steps in the management 
of obstetric emergencies (ESMOE). This involves trainers visiting all 
health districts and carrying out training on mannequins and other 
visual aids on the emergency management of common conditions 
causing maternal deaths. 
Previous SMRs have not identified cases of acute fatty liver of 
pregnancy (AFLP), but there is an impression that this condition 
does occasionally occur.2,3 Whether these deaths should be grouped 
under HDP is debatable. AFLP is defined as a condition that 
occurs abruptly in the second half of pregnancy and presents 
with increasing jaundice and right upper quadrant pain. The liver 
enzymes (transaminases) are abnormal and patients go on to develop 
coagulopathy and encephalopathy. Treatment involves supportive 
measures and delivery of the fetus. On pathological examination the 
liver shows fatty changes in the hepatocytes.12 
There were 3 cases of maternal death grouped under AFLP. All 
took place at the same tertiary hospital and its geographical drainage 
area, all the patients were relatively young (26 - 30 years), parity 2 
and in the second half of pregnancy, and all presented with jaundice 
and abdominal pain. One had mild hypertension, 2 had autopsies 
in keeping with fatty changes in the liver, and the third was said to 
have had all the clinical features of AFLP. As they were all from the 
same geographical area, the questions of viral infections, drug-related 
effects, or heavy alcohol intake are raised.
Conclusion
The majority of maternal deaths from hypertensive disorders in 
South Africa are associated with avoidable factors and substandard 
care. The challenge is to implement the recommendations arising 
from the SMRs. There is evidence from the 2005 - 2005 report that 
maternal deaths due to hypertension are decreasing, but more effort 
needs to be put into increasing the skills of health care professionals 
and  improving the information on maternity care that we provide to 
women, fathers, families and  communities.
  1.    National Committee on Confidential Enquiries into Maternal Deaths. Saving Mothers Fourth Report 
2005-2007. Pretoria: Department of Health, 2009.
  2.    National Committee on Confidential Enquiries into Maternal Deaths. Saving Mothers: Third Report 
on Confidential Enquiries into Maternal Deaths in South Africa 2002-2004. Pretoria: Department of 
Health, 2005. 
  3.    National Committee on Confidential Enquiries into Maternal Deaths. Saving Mothers: Third Report 
on Confidential Enquiries into Maternal Deaths in South Africa 1999-2001. Pretoria: Department of 
Health, 2006.
  4.    The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence 
from the Collaborative Eclampsia Trial. Lancet 1995;345:1455-1463.
  5.    Langer A, Villar J, Tell K, et al. Reducing eclampsia related deaths – a call to action. Lancet 2008;371:705-
706.
  6.    Department of Health. Guidelines for Maternity Care in South Africa. 3rd ed. Pretoria; Department 
of Health, 2007 
  7.    Department of Health. Essential Steps in the Management of Obstetric Emergencies. Pretoria: 
Department of Health, 2008.
  8.    Martin Jr NL, Thigpen MF, Moore RC, et al. Stroke and pre-eclampsia and eclampsia: a paradigm shift 
focussing on systolic blood pressure. Obstet Gynecol 2005;105:246-254.
  9.    Neilson J. Pre-eclampsia and eclampsia. In: Lewis G and CEMACH. Why Mothers Die 2003-2005. 
London: RCOG Press, 2007: 72. 
10.    Paruk F, Moodley J. Untoward effects of rapid-acting antihypertensive agents.  In: Arukumaran S, 
Moodley J, eds. Best Practice and Research Clinical Obstetrics and Gynaecology. London: Harcourt 
Publishers, 2001: 491-506.
11.    Schutte J. Schuitmaker NW, van Roosmalen J, Steeger EA. Dutch Maternal Mortality Committee. Br J 
Obstet Gynaecol 2008;115(6):732-736.
12.    Barber MA, Equiluz I, Martin A, Placencia W, Valle L, Garcia JA. Acute fatty liver of pregnancy: analysis 
of five consecutive cases from a tertiary centre. J Obstet Gynecol 2010; 30(3):241-243.
Gastro-intestinal cytomegalovirus (CMV) infection manifests as 
oesophagitis, gastritis, enteritis and colitis.1,2 Reports of duodenal 
involvement are rare.3 We found only one reported CMV-induced 
pseudotumour of the duodenum and 14 CMV-induced gastro-
intestinal pseudotumours.4-6
Case report
A 35-year-old woman presented with cholestatic jaundice and 
partial bowel obstruction following 3 months’ history of intermittent 
abdominal pain, nausea and vomiting. She had been diagnosed HIV 
positive 2 years before presentation, and had had no further follow- 
up. An abdominal ultrasound scan demonstrated splenic micro-
abscesses, mesenteric and para-aortic lymphadenopathy and an 
indiscrete mass in the region of the head of the pancreas. A computed 
tomography (CT) scan (Fig. 1) confirmed a mass inseparable from 
the first part of the duodenum (D1) in the region of the head of 
the pancreas, compressing the common bile duct (CBD). Magnetic 
resonance cholangiopancreatography (MRCP) (Fig. 2) demonstrated 
dilated intrahepatic ducts and a long distal CBD stricture. Empiric 
tuberculosis (TB) treatment was started in view of the intra-
abdominal lymph nodes, splenic micro-abscesses and pancreatic 
mass, with poor clinical response.
Because of the patient’s poor clinical response to TB treatment 
gastroscopy was performed, and an exophytic lesion at the second 
part of the duodenum (D2) was encountered which the scope was 
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unable to pass. Biopsies from this obstructing mass demonstrated a 
florid CMV duodenitis.
The patient was commenced on intravenous ganciclovir for 2 
weeks, with a moderate clinical response but without complete 
resolution of inflammatory markers and liver function. Gastroscopy 
performed 1 week after completion of intravenous  ganciclovir 
revealed almost complete resolution of the exophytic mass, and the 
endoscope was able to pass to the ampulla. Duodenal biopsy from 
the area of the mass demonstrated two poorly formed epitheloid 
granulomas within the lamina propria, with a Ziehl-Neelsen stain 
highlighting several acid-fast bacilli. No viral cytopathic effect was 
noted in this specimen. At this stage she had been on TB treatment 
for 1 month and had been treated with ganciclovir for 2 weeks. 
Endoscopic retrograde cholangiopancreatography was done 
because liver function did not improve and the patient experienced 
ongoing right upper quadrant pain. The duodenal cap was markedly 
diseased, and mildly dilated intrahepatic ducts were demonstrated 
with no distal filling of the CBD in keeping with a long distal CBD 
stricture. It was considered that the stricture was not typical of 
extrinsic compression, and a wide sphincterotomy and stent was 
inserted. To confirm CMV as the pathogen responsible for the 
CBD stricture, biopsy of the CBD and/or culture of the bile aspirate 
for CMV should ideally have been undertaken. The patient was 
discharged on oral ganciclovir for 3 weeks and continuing standard 
TB treatment. Antiretrovirals were initiated within a few weeks of 
discharge, comprising lamivudine, stavudine and efavirenz, at a CD4 
count of 53 cells/µl. 
The patient improved slowly over the next few months. She 
continued taking antiretrovirals with minimal complications, and 
completed 9 months of TB treatment. At the time of writing she 
was clinically well with an undetectable viral load and reported 
improvements in all aspects of her life including work and leisure. 
She reported a return of libido and was practising safe sex with a 
discordant partner. A repeat endoscopy one year after her initial 
presentation demonstrated a normal duodenum with unremarkable 
histology. Liver function improved significantly and was stable at the 
time of writing.
Discussion
CMV is an important pathogen, causing a wide spectrum of 
disease from asymptomatic infection to mononucleosis syndrome 
in immunocompetent individuals to disseminated disease in 
immunocompromised individuals.
Once acquired by symptomatic or asymptomatic primary infection, 
CMV persists indefinitely in various cell types and organs including 
salivary glands, lung, liver, kidney, bowel, pancreas, adrenal glands 
and central nervous system. The cellular inflammatory response 
consists of plasma cells, lymphocytes and monocyte-macrophages. 
Granulomatous reactions occasionally develop, usually in the 
liver. Infection will usually remain latent. Reactivation syndromes 
frequently develop when T-lymphocyte-mediated immunity is 
compromised. 
Active significant CMV infection is sometimes difficult to diagnose 
definitively in patients with advanced HIV disease because of its 
propensity to infect rapidly dividing cells and the frequent presence 
of other opportunistic infections.1 Fatal CMV infection is often 
associated with persistent viraemia and the involvement of multiple 
organ systems, often in conjunction with another opportunistic 
infection such as TB. The guidelines for ganciclovir use remain 
anecdotal.
CMV is often noted in pathological specimens and should not be 
viewed as incidental, even in the presence of another infection. CMV 
pseudotumour should be considered as a differential diagnosis in 
mass lesions of the gastro-intestinal tract in the immunocompromised 
patient. The tumour does respond to antiviral treatment.4
The exact incidence and cause of HIV cholangiopathy has yet to 
be determined, but infection-related damage to the biliary tree has 
been suggested and CMV infection appears to be one possible cause.
This is the first reported case of CMV-related duodenitis, 
pseudotumour and cholangiopathy of which we are aware. CMV 
is emerging as an important pathogen in patients with advanced 
HIV and other immunocompromised hosts. We propose that CMV 
infection associated with a concurrent infection is clinically significant 
in such patients. It should not be overlooked even in the presence of 
other opportunistic infection, and further research is required into 
how best to treat CMV and HIV co-infection.
Approval was obtained from the Ethics Committee of the University of 
the Witwatersrand. There were no conflicts of interest. Written consent 
was obtained from the patient.
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Fig. 2. MRCP demonstrating dilated intrahepatic biliary system.
Fig. 1. CT scan – coronal view showing mass inseparable from duodenum.
